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The retinoid receptors have major roles throughout develop-
 
ment, even in the absence of ligand. Here, we summarize
an emerging theme whereby gene repression, mediated by
 
unliganded retinoid receptors, can dictate cell fate. In
addition to activating transcription, retinoid receptors
actively repress gene transcription by recruiting cofactors
that promote chromatin compaction. Two developmental
 
processes for which gene silencing by the retinoid receptors
 
is essential are head formation in 
 
Xenopus
 
 and skeletal
development in the mouse. Inappropriate repression, by
 
oncogenic retinoic acid (RA)* receptor (RAR) fusion proteins,
blocks myeloid differentiation leading to a rare form of
 
leukemia. Our current understanding of the developmental
role of retinoid repression and future perspectives in this
ﬁeld are discussed.
 
The importance of retinoids and their receptors in development
 
has been recognized for years and is the topic of a number of
comprehensive reviews (Mark et al., 1999; Sucov and Evans,
1995; Wolf, 1984; Zile, 1998, 2001). Much less dated is our
 
knowledge of the receptors as factors that mediate chromatin
compaction and decompaction (for review see Glass and
Rosenfeld, 2000). This, combined with the realization that
chromosomal architecture and stability profoundly influence
cell differentiation, has intensified interest in the develop-
mental role of these and other nuclear receptors. Although
traditionally thought of solely as ligand transducers, unliganded
 
retinoid receptors are emerging as major players in many
cellular processes, through their role as gene repressors.
Here, we concentrate on repression by unliganded retinoid
receptors as a mechanism underlying important embryonic
events.
 
The retinoid receptors: recruiters of chromatin 
remodeling factors
 
The retinoids include natural forms of vitamin A such as
retinol, and its derivatives such as retinal acid and RA. RA is
the natural ligand for a class of nuclear receptors comprised
of two subfamilies: the RARs and the retinoid X receptors
 
(RXRs), each containing three members: 
 
 
 
, 
 
 
 
, and 
 
 
 
 (Leid
et al., 1992). Several isoforms, with distinct amino termini,
expression patterns, and functional properties, have also
 
been identified. The pleiotropic effects of retinoids are mediated
through RAR-RXR heterodimers or RXR homodimers
 
bound to bipartite response elements (RAREs) typically
located upstream of target genes.
Like other nuclear receptors, RAR and RXR dimers
modulate transcription by recruiting coactivators and
corepressors. When ligand is present, conformational changes
in the receptor reorient the ligand-binding domain, expos-
ing a binding site for coactivators. These coactivators, in-
cluding CBP/p300, p300/CBP-associated factor, and p160
family members (such as RIP140, and SRC), interact with
the receptors through a motif containing the sequence
LXXLL. In turn, they recruit proteins, many of which possess
histone acetyltransferase (HAT) activity. In the absence of
ligand, RARs bind to DNA and interact with corepressors
such as nuclear receptor corepressor (NCoR)-1 and NCoR-2/
SMRT (silencing mediator of RAR and thyroid hormone
receptor) (Chen et al., 1996; Horlein et al., 1995), also
through LXXLL motifs. NCoRs are among the factors that
recruit mSin3A and its associated histone deacetylases
 
(HDACs), although both corepressors can also interact directly
with HDACs in an mSin3A-independent manner (Huang
et al., 2000). Acetylation of the lysine residues of histone
tails promotes a relaxed chromatin conformation that enables
transcriptional activity, whereas histone deacetylation reverses
these effects, maintaining chromatin in the condensed state
that typifies transcriptional repression.
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Although the retinoid receptors are typically thought to
interact with corepressors primarily in the absence of ligand,
there are exceptions. RAREs that are spaced 1 bp apart bind
RAR/RXR heterodimers in a polarity that is opposite to
those separated by 5 bp, resulting in decreased ability of
NCoR to dissociate from receptors upon ligand binding
(Kurokawa et al., 1995). Surprisingly, at these response ele-
ments, NCoR binding in the presence of ligand results in
gene activation through recruitment of HDAC3 (Jepsen et
al., 2000). Therefore, NCoR or HDAC recruitment does
not necessarily imply repression, and is not limited to unli-
ganded receptors, rather the role of NCoR recruitment to
the retinoid receptors may be encrypted in the response ele-
ments within promoters. The importance of RARE configu-
ration in dictating receptor action is further revealed by the
identification of a completely novel type of response element
composed of two half-binding sites separated by 87 nucle-
otides. Surprisingly, this RARE seems to be a target of an
unliganded phosphorylated RAR
 
 
 
 homodimer, never de-
scribed previously (Brondani et al., 2002). As researchers
continue to characterize the response elements, more com-
plex roles for these receptors will likely be uncovered. Fi-
nally, the recent discovery of a ligand-dependent corepressor
(LCoR), which causes gene repression through liganded nu-
clear hormone receptors including RARs, further highlights
the level of complexity of receptor function, as liganded re-
ceptors have traditionally been considered to activate tran-
scription (Fernandes et al., 2003). LCoR possesses an
LXXLL motif (similar to the other cofactors described)
through which it interacts with the receptors, and can evoke
repression through an HDAC-dependent or -independent
manner (Fernandes et al., 2003).
Receptor-mediated repression seems as important as ac-
tivation throughout various embryonic processes (Man-
nervik et al., 1999). NCoR-deficient embryos exhibit
abnormalities in erythrocyte, thymocyte, and neural devel-
opment and generally die around embryonic age (E)16
(Jepsen et al., 2000). Moreover, NcoR has been distin-
guished as a principle regulator of neural stem cell fate, in
that its activity promotes self-renewal of these cells, re-
pressing their differentiation into astrocytes (Hermanson
et al., 2002). The absence of HDAC1 is also detrimental,
resulting in embryonic lethality before E10.5, attributed to
major proliferation defects and developmental retardation
(Lagger et al., 2002). This is consistent with the effects of
knocking out other components of repressor complexes in
invertebrates (for review see Ahringer, 2000), and with the
block in metamorphosis seen in tadpoles treated with the
HDAC inhibitor, trichostatin A (Sachs et al., 2001). More
specifically, NCoR recruitment by unliganded thyroid re-
ceptors represses expression of genes in preparation for tad-
pole metamorphosis (Sachs et al., 2002). Together, these
findings support a prominent role for gene silencing in de-
velopment. This is further emphasized by the widespread
expression of LCoR in fetal tissues, including high levels in
two-cell embryos (Fernandes et al., 2003). Here, we dis-
cuss the developmental role of repression by the retinoid
receptors, highlighting two systems that are quite distinct
from one another, but surprisingly similar in their require-
ment for RAR-mediated repression.
 
Head formation in 
 
Xenopus
 
Studies showing a requirement for RAR-mediated repression
during head formation in 
 
Xenopus
 
 were the first to uncover a
major developmental role for active repression by retinoid
receptors. Neural induction and anteroposterior (A-P) pat-
terning of the neuroectoderm is largely regulated by signals
secreted from the dorsal blastopore region, or “Spemann’s
organizer,” and requires the inhibition of factors that pro-
mote epidermal fate and formation of more posterior struc-
tures such as the trunk (fro review see Sasai and De Robertis,
1997). In response to treatment of early embryos with RA,
or microinjection of constitutively active RARs, there is a
posteriorization of otherwise anterior neural tissue, or even
anterior truncations (for review see Blumberg et al., 1997).
In contrast, expression of anterior markers is enhanced by
microinjection of mRNA encoding a dominant–negative
version of the RAR
 
 
 
 (dnRAR
 
 
 
) (Blumberg et al., 1997).
These findings imply that RA must be absent or available at
very low levels for appropriate patterning of anterior struc-
tures—an implication that is consistent with the expression
of enzymes that regulate RA concentration. RALDH2 (retin-
aldehyde dehydrogenase 2) is important for RA produc-
tion, and cytochrome p450, 26 (CYP26) metabolizes RA. In
 
Xenopus
 
, Cyp26 is expressed in future anterior CNS struc-
tures, whereas Raldh2 is restricted to the posterior region,
suggesting a gradient of RA, with the lowest levels in the an-
terior regions during neural induction. Interestingly, RAR
 
 
 
and RAR
 
 
 
 are expressed in prospective anterior tissues, de-
spite the apparent absence of RA in these regions, and de-
spite the sensitivity of these tissues to exogenous RA treat-
ment (Ellinger-Ziegelbauer and Dreyer, 1991, 1993; Pfeffer
and De Robertis, 1994). A convincing explanation for this
paradox is that the repressive function of unliganded RARs,
rather than simply an absence of RA, is essential for proper
head formation (Koide et al., 2001).
Both NCoR-1 and -2 are expressed in the developing
CNS, overlapping with RAR
 
 
 
 transcripts (Koide et al.,
2001). Treatment with AGN193109, an inverse agonist that
promotes the repressive function of RAR, reverses RA-
induced head truncations, causes an enlargement of the head
and reduction in the tail, and up-regulates the expression
of anterior markers. Microinjection of c-SMRT (NCoR-2)
or morpholino antisense oligonucleotides against either
xRAR
 
 
 
1, or xRAR
 
 
 
2 alone, or in combination, gives rise to
posteriorized embryos, decreases the expression of anterior
markers, and causes a reduction or loss in anterior structures
including the head and cement gland (Koide et al., 2001).
These effects can be rescued by microinjection of dnRAR
 
 
 
.
Together, these results strongly suggest that a loss of RAR-
mediated repression underlies the head formation defects
caused by RA, and that RARs are not only transcriptional
activators that transduce an RA signal, but also function in
their unliganded form as gene repressors. Accordingly, over-
expression of CYP26 in 
 
Xenopus
 
 causes an expansion of the
region expressing anterior markers (Hollemann et al., 1998),
perhaps due to increased repression by the RARs in cells
normally exposed to higher levels of RA. Conversely, CYP26
mutant mice exhibit abnormal patterning of the anterior
CNS (Abu-Abed et al., 2001). These effects are not surpris-
ing, as tight control of ligand concentration would intu-T
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itively be critical given the distinct functions reported for
unliganded versus liganded receptors.
 
Skeletal development
 
Similar to 
 
Xenopus
 
 head formation, the status of RAR activ-
ity largely influences the fate of skeletal progenitor cells in
mice. Most of the vertebrate skeleton is formed on a cartilag-
inous template. In response to various cues, condensations
prefiguring the cartilage skeleton form, followed by the dif-
ferentiation of condensed cells into chondroblasts—the early
matrix-producing cells of cartilage. Dramatic skeletal abnor-
malities are elicited in mice by excess RA treatment (for re-
views see Underhill et al., 1995; Underhill and Weston,
1998), or by ectopic expression of a weak constitutively ac-
tive RAR
 
 
 
1 in the developing limbs (Cash et al., 1997). The
underlying cause of these defects is a failure of condensed
mesenchymal cells to differentiate into chondroblasts (Wes-
ton et al., 2000, 2002).
Primary cultures of mouse limb mesenchyme recapitulate
the in vivo chondrogenic sequence, in that various conden-
sations of mesenchymal cells appear within a day or two of
culture initiation, followed by the differentiation of these
cells into chondroblasts, producing detectable nodules of
cartilage (Ahrens et al., 1977). Treatment of these cultures
with RAR antagonists increases nodule formation and in-
duces expression and activity of Sox9, a transcription factor
required for chondroblast differentiation (Weston et al.,
2002). In addition, Sox9 activity is dramatically induced by
the introduction of dnRAR
 
 
 
 or dnRXR
 
 
 
 into the cultures,
and is inhibited by transfection of constitutively active ver-
sions of these receptors. The antagonist-induced increase in
cartilage formation is blocked by the HDAC inhibitor tri-
chostatin A, whereas the presence of a dominant–negative
NCoR-1, which is unable to recruit HDACs, attenuates the
antagonist-induced increase in Sox9 activity (Weston et al.,
2002). These results indicate that recruitment of HDACs by
RARs is essential for chondroblast differentiation. Consis-
tent with this, expression of CYP26A1 and B1 is elevated in
chondroprogenitors (Abu-Abed et al., 2002), suggesting a
decrease of RA in these cells, which in turn would support
the recruitment of HDACs to unliganded RARs and thus
promote differentiation. It is worth noting that the oxidized
derivatives of RA do not appear to be involved in retinoid
signaling (Niederreither et al., 2002). Together, there is com-
pelling evidence for a requirement for RAR-mediated repres-
sion in differentiation of murine skeletal progenitors, which
closely parallels that described for head formation in 
 
Xenopus
 
.
 
Comparison between two distinct developmental 
systems: novel insights
 
Similarities in the role of gene repression by unliganded
RARs in 
 
Xenopus
 
 CNS and mouse skeletal development pro-
vide some useful insights. For instance, the dynamic, and of-
ten abundant expression of the retinoid receptors does not
necessarily correspond to the spatial and temporal availabil-
ity of RA during development. This is evident by the requi-
site expression of RARs during 
 
Xenopus
 
 head formation, in
regions not only devoid of RA, but where RA has detrimen-
tal effects. Similarly, during skeletal development in mouse
 
limb buds, RAR
 
 
 
 and RAR
 
 
 
 are highly expressed in chon-
droprogenitors despite high levels of CYP26 in these cells. In
fact, excess RA during cartilage formation causes profound
skeletal anomalies. Therefore, it is reasonable to infer that
these receptors have important functions beyond transduc-
ing a retinoid signal, and that the teratogenic effects of ex-
cess RA can be caused, at least in part, by the derepression of
otherwise silenced genes.
A finding common to both analyses is that manipulation
of a single receptor isoform (xRAR
 
 
 
1 or -2 in the case of
head formation and RAR
 
 
 
1 for skeletal development) has
profound phenotypic consequences. These findings are sur-
prising given the presumed redundancy between RAR fam-
ily members, inferred from mouse knockout studies in
which ablation of multiple receptor subtypes is necessary to
produce noticeable phenotypes (Lohnes et al., 1994; Men-
delsohn et al., 1994). Similarly, animals in which thyroid
hormone receptors have been knocked out develop a com-
pletely normal central nervous system, whereas mice con-
taining a mutated thyroid hormone receptor 
 
 
 
, in which the
ligand binding function of the receptor subtype is abolished,
exhibit severe neurological development and dysfunction
(Hashimoto et al., 2001). The latter effects are more consis-
tent with the effects of congenital hypothyroidism and thy-
roid hormone resistance syndrome, both characterized by se-
vere CNS dysfunction. Such discrepancies may be due to the
distinct approaches taken to manipulate receptor function.
In knockout mice, receptors are absent and thus cannot acti-
vate or repress target genes, whereas the use of selective an-
tagonists or dominant–negative versions of the receptors, in-
hibits transcriptional activation, but maintains or enhances
receptor-mediated repression. A full explanation for the lack
of severe phenotypes in some of the receptor-knockout mice
must await further functional studies.
In both systems discussed, RAR-mediated repression leads
to the activation of specific markers of the differentiated phe-
notype. To date, the direct target genes whose repression
causes the onset of differentiation have not been identified.
Obvious candidates are genes satisfying various conditions: (i)
they are expressed in progenitors but down-regulated just be-
fore, or during, differentiation; (ii) they interfere with differ-
entiation and/or promote proliferation of progenitors; (iii)
they are transcriptionally regulated by RA; and (iv) they con-
tain RAREs within their promoters. To date, there is little ev-
idence to suggest that any genes satisfy all conditions. Ongo-
ing studies in our labatoriess and others, however, are focused
on unraveling the mechanisms whereby RAR-mediated re-
pression leads to cell differentiation in both the 
 
Xenopus
 
model of head formation and the mouse model of skeletal de-
velopment. To this end, 
 
Crescent
 
, a gene whose overexpression
interferes with anterior patterning (Pera and De Robertis,
2000), appears to be up-regulated by RA treatment according
to microarray studies (unpublished data). 
 
Crescent
 
 is expressed
in the head organizer region at the early gastrula stage in 
 
Xeno-
pus
 
, but down-regulated by the tailbud stage (Pera and De
Robertis, 2000). Microinjection of 
 
Crescent
 
 mRNA leads to
cyclopia and a reduction or even loss in the most anterior ce-
ment gland (Pera and De Robertis, 2000). Given the induc-
tion of 
 
Crescent
 
 by RA, this gene represents a logical candidate
for repression by unliganded RARs in this system.T
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Potential direct targets of RAR-mediated repression dur-
ing chondroblast differentiation in the mouse, include mem-
bers of the 
 
Fgf
 
 and 
 
Wnt
 
 genes as well as members of the ho-
meobox (
 
Hox
 
) genes, including 
 
Msx1
 
. Members from all
gene families figure prominently in skeletal development,
and several are demonstrated targets of retinoid signaling. In
addition, several of the 
 
Hox
 
 genes have been shown to pos-
sess RAREs in their promoters (for review see Ross et al.,
2000) and RAREs have been identified upstream of one of
the 
 
Fgf
 
 family members (Brondani et al., 2002). 
 
Msx1
 
 repre-
sents one of the best candidates, as this gene is expressed in
proliferating chondroprogenitors but not in differentiated
chondroblasts, during limb development, and its maintained
expression has been associated with an inhibition in differ-
entiation (for reviews see Davidson, 1995; Bendall and
Abate-Shen, 2000). 
 
Msx
 
 misexpression studies implicate
these genes as promoters of cell proliferation and inhibitors
of differentiation during many processes including chondro-
genesis (Hu et al., 2001; Mina et al., 1996). Moreover, RA
induces 
 
Msx1
 
 expression in EC cells (Shen et al., 1994).
Similarly, we have observed an expansion of 
 
Msx1
 
 expression
in the limbs of transgenic mice ectopically expressing a con-
stitutively active RAR
 
 
 
 (unpublished data). Aside from
those mentioned, evidence is currently too scarce to postu-
late additional genes that are direct targets of retinoid repres-
sion during both 
 
Xenopus
 
 head formation and mouse skeletal
development. A more comprehensive list of DNA-binding
targets for the nuclear receptors will undoubtedly come from
ongoing microarray analyses and from studies coupling
chromatin immunoprecipitation with microarrays of human
and mouse intergenic sequences, as has been done in yeast
(Lee et al., 2002; Ren et al., 2000).
 
In the wrong place at the wrong time: RAR-mediated 
repression and acute myeloid leukemia
 
The impact of RAR-mediated repression is underscored by
the pathogenesis of acute promyelocytic leukemia (APL).
APL is characterized by a block at various stages of hemato-
poietic progenitor cell (HPC) differentiation and, to date,
has been associated with five translocation events, each fus-
ing RAR
 
 
 
 to another protein (for reviews see Lin et al.,
2001; Zelent et al., 2001). RARs are critical during myeloid
differentiation (Collins et al., 1990; Onodera et al., 1995;
Tsai and Collins, 1993). Unlike head formation or skeletal
development, where RAR
 
 
 
-mediated repression promotes
differentiation, in the case of APL, RAR
 
 
 
 fusion proteins
prevent myeloid cell differentiation (Grignani et al., 1993;
Rousselot et al., 1994), which is attributed to an inability of
these fusion proteins to dissociate from repressor complexes
in the presence of physiological levels of RA (for review see
in Lin et al., 2001). The fusion proteins exhibit enhanced
corepressor binding efficiency, presumably causing irrevers-
ible silencing of genes required for myeloid differentiation.
Incidentally, included among these targets are perhaps genes
not normally bound to RARs, but targeted nonetheless, by
their novel fusion partners. Consequently, myeloid cells
continue to proliferate, expanding the number of progeni-
tors normally fated to undergo cell differentiation. Similarly,
in mice treated with RAR panantagonists, granulocyte pre-
cursor numbers are substantially increased within all he-
 
matopoietic compartments, despite no change in cell death
of mature granulocytes or progenitors (Walkley et al., 2002).
Therefore, the fine balance between proliferation and differ-
entiation during normal hematopoiesis seems to rely on ap-
propriate gene repression by RARs.
 
Summary and future directions
 
Head formation in 
 
Xenopus
 
 and skeletal development in
mice are unique in that they involve differentiation events
that are inhibited by RA, despite RA having a general role as
an inducer of differentiation in many cell types. Given these
opposite roles for RA in varying systems, it is plausible that
receptor-mediated repression similarly has dual roles, being
required both for induction of differentiation (in the case of
neural development in 
 
Xenopus
 
 and skeletogenesis in mice),
and for enhancing the proliferation of precursors, while in-
hibiting differentiation in other cells such as hematopoietic
precursors. In this respect, the receptors can be thought of as
molecular devices through which precise global control of
gene transcription is achieved during development, through
the combined action of liganded and unliganded receptors.
The dynamic expression of receptors throughout develop-
ment, irrespective of ligand availability, supports this idea.
As researchers unravel the mode of action for the nuclear
receptors in more precise detail, a major challenge will be to
place these molecular mechanisms into the context of the
developmental processes affected by these receptors. This
will require cataloguing of the genes directly acted upon by
the receptors as well as a clear understanding of the develop-
mental role of these genes. On a more molecular level, use of
technologies such as fluorescence resonance energy transfer
to monitor interactions between individual receptor sub-
types and cofactors within live cells will be useful for relating
cofactor exchange with specific developmental processes
(Llopis et al., 2000). The notion of alternative HDACs be-
ing recruited may provide an additional level of complexity
to the function of the receptors. It also remains to be shown
how gene repression is influenced by posttranslational modi-
fications, and by interactions with other (non-RXR) part-
ners. Finally, an interesting possibility worth exploring is
whether different receptor subtypes (or isoforms thereof) are
distinct in their capacities to mediate gene repression. In-
deed, recent findings suggest differences in cofactor stoichi-
ometries and patterns of interaction among the distinct RAR
subtypes (Germain et al., 2002), as RAR
 
 
 
 and RAR
 
 
 
 were
recently shown to be transcriptional activators even in the
absence of ligand, contrasting the strong repressing activity
of unliganded RAR
 
 
 
 (Hauksdottir et al., 2003). Undoubt-
edly, the need for studies of this nature and the ongoing
identification of novel roles for retinoid receptors will con-
tinue to fuel interest in the field of retinoid signaling and de-
velopment.
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